United Therapeutics Corporation (NASDAQ:UTHR) Q3 2024 Earnings Call Transcript

United Therapeutics Corporation (NASDAQ:UTHR) Q3 2024 Earnings Call Transcript October 30, 2024

United Therapeutics Corporation misses on earnings expectations. Reported EPS is $6.39 EPS, expectations were $6.43.

Operator: Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2024 Earnings Webcast. My name is Dave, and I will be your conference operator today. [Operator Instructions] Please note this call is being recorded. I would now like to turn the webcast over...